Conjunction adjuvants immunologic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Lymph Nodes T-Lymphocytes Spleen Dendritic Cells Th1 Cells Cells, Cultured CD4-Positive T-Lymphocytes CD8-Positive T-Lymphocytes Th2 Cells Cell Line T-Lymphocytes, Cytotoxic Nasal Mucosa Cell Line, Tumor B-Lymphocytes Axilla Mucous Membrane

Organisms13

Mice, Inbred BALB C Mice, Inbred C57BL Rats, Inbred Lew Quillaja Mice, Knockout Rabbits Mice, Inbred C3H Guinea Pigs Mice, Inbred Strains Escherichia coli Mice, Transgenic Cattle Rats, Sprague-Dawley

Diseases31

Breast Neoplasms Neoplasm Recurrence, Local Arthritis, Experimental Lymphatic Metastasis Hypersensitivity, Delayed Adenocarcinoma Colonic Neoplasms Disease Models, Animal Arthritis Melanoma Rectal Neoplasms Neoplasm Metastasis Lung Neoplasms Colorectal Neoplasms Recurrence Pancreatic Neoplasms Neoplasms, Hormone-Dependent Brain Neoplasms Sarcoma Stomach Neoplasms Neoplasm Invasiveness Skin Neoplasms Carcinoma Bone Neoplasms Inflammation Neoplasms Autoimmune Diseases Amenorrhea Disease Progression Carcinoma, Non-Small-Cell Lung Liver Neoplasms

Chemicals and Drugs96

Adjuvants, Immunologic Freund's Adjuvant Adjuvants, Pharmaceutic Aluminum Hydroxide Tamoxifen Fluorouracil Antineoplastic Agents, Hormonal Vaccines Cyclophosphamide Immunoglobulin G Vaccines, Subunit Antineoplastic Agents Ovalbumin Squalene Levamisole Saponins Aromatase Inhibitors Cancer Vaccines Polysorbates Cholera Toxin Vaccines, Synthetic Methotrexate Acetylmuramyl-Alanyl-Isoglutamine Doxorubicin Receptors, Estrogen Vaccines, DNA Bacterial Vaccines Epirubicin ISCOMs Antigens Lipid A Interferon-gamma Nitriles Recombinant Proteins Cytokines Leucovorin Adjuvants, Anesthesia Triazoles Vaccines, Inactivated Receptor, erbB-2 Cisplatin Anthracyclines Hemocyanin Influenza Vaccines Antibodies, Bacterial Antimetabolites, Antineoplastic Antibodies, Viral Antibodies, Monoclonal Tumor Markers, Biological Oligodeoxyribonucleotides Antigens, Bacterial Receptors, Progesterone Immunoglobulin A Viral Vaccines Antibodies Tegafur Malaria Vaccines Cord Factors Mineral Oil Emulsions Bacterial Toxins Enterotoxins Antigens, Neoplasm Tetanus Toxoid Liposomes Interleukin-12 Recombinant Fusion Proteins Antibodies, Monoclonal, Humanized Peptide Fragments Antineoplastic Agents, Alkylating RNA, Messenger Paclitaxel Semustine BCG Vaccine Immunoglobulin A, Secretory Epitopes Peptides Taxoids Antibodies, Protozoan Tuberculosis Vaccines Bacterial Proteins Estrogen Receptor Modulators Antigens, Protozoan AIDS Vaccines Poly A-U Escherichia coli Proteins Organoplatinum Compounds Dacarbazine Drug Combinations Lipopolysaccharides Goserelin Epitopes, T-Lymphocyte Membrane Proteins Immunoglobulin E Interferon-alpha Deoxycytidine

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Chemotherapy, Adjuvant Radiotherapy, Adjuvant Combined Modality Therapy Immunization Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Neoplasm Staging Administration, Intranasal Prognosis Survival Analysis Arthritis, Experimental Survival Rate Vaccination Follow-Up Studies Retrospective Studies Neoadjuvant Therapy Randomized Controlled Trials as Topic Clinical Trials as Topic Mastectomy Drug Administration Schedule Kaplan-Meier Estimate Lymphocyte Activation Disease Models, Animal Prospective Studies Immunotherapy Injections, Subcutaneous Immunohistochemistry Administration, Oral Enzyme-Linked Immunosorbent Assay Proportional Hazards Models Immunization, Secondary Injections, Intramuscular Lymph Node Excision Multivariate Analysis Mastectomy, Segmental Injections, Intradermal Predictive Value of Tests Risk Factors Sensitivity and Specificity Radiotherapy Injections, Intraperitoneal Analysis of Variance Risk Assessment Actuarial Analysis Models, Biological Clinical Trials, Phase III as Topic Brachytherapy Reproducibility of Results Random Allocation Radiotherapy Dosage Immunotherapy, Active Magnetic Resonance Imaging Gastrectomy Flow Cytometry Mastectomy, Radical Cohort Studies Polymerase Chain Reaction Postoperative Care SEER Program Immunization, Passive Drug Therapy, Combination Double-Blind Method Patient Selection Mastectomy, Modified Radical Gene Expression Profiling Pilot Projects Reverse Transcriptase Polymerase Chain Reaction Models, Molecular Feasibility Studies

Phenomena and Processes24

Time Factors Antibody Formation Immunity, Mucosal Immunity, Cellular Immunity, Humoral Amino Acid Sequence Lymphocyte Activation Dose-Response Relationship, Immunologic Dose-Response Relationship, Drug Base Sequence Postmenopause Premenopause Mutation Sensitivity and Specificity Signal Transduction Kinetics Protein Binding Menopause Algorithms Cell Proliferation Immune Tolerance Phenotype Antibody Specificity Plasmids

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture2

Polysorbates Liposomes

Humanities1

Quality of Life

Information Science6

Survival Rate Molecular Sequence Data Amino Acid Sequence Base Sequence Algorithms SEER Program

Health Care31

Immunization Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Vaccination Follow-Up Studies Retrospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Kaplan-Meier Estimate Prospective Studies Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Risk Factors Sensitivity and Specificity Age Factors Analysis of Variance Risk Assessment Actuarial Analysis Clinical Trials, Phase III as Topic Reproducibility of Results Random Allocation Cohort Studies Postoperative Care SEER Program Double-Blind Method Patient Selection Pilot Projects Feasibility Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Adjuvants, Immunologic Chemotherapy, Adjuvant Freund's Adjuvant Radiotherapy, Adjuvant Adjuvants, Pharmaceutic Breast Neoplasms Aluminum Hydroxide Combined Modality Therapy Immunization Treatment Outcome Tamoxifen Antineoplastic Combined Chemotherapy Protocols Fluorouracil Disease-Free Survival Neoplasm Staging Mice, Inbred BALB C Neoplasm Recurrence, Local Antineoplastic Agents, Hormonal Vaccines Administration, Intranasal Prognosis Survival Analysis Time Factors Antibody Formation Arthritis, Experimental Cyclophosphamide Immunoglobulin G Vaccines, Subunit Mice, Inbred C57BL Antineoplastic Agents Survival Rate Lymphatic Metastasis Vaccination Ovalbumin Follow-Up Studies Squalene Immunity, Mucosal Levamisole Retrospective Studies Saponins Aromatase Inhibitors Cancer Vaccines Molecular Sequence Data Polysorbates Cholera Toxin Lymph Nodes Vaccines, Synthetic Methotrexate Acetylmuramyl-Alanyl-Isoglutamine Hypersensitivity, Delayed Neoadjuvant Therapy Adenocarcinoma Doxorubicin Randomized Controlled Trials as Topic Receptors, Estrogen Vaccines, DNA Rats, Inbred Lew Bacterial Vaccines Epirubicin Clinical Trials as Topic ISCOMs Mastectomy Colonic Neoplasms Drug Administration Schedule Antigens Immunity, Cellular Lipid A Interferon-gamma Nitriles T-Lymphocytes Spleen Dendritic Cells Th1 Cells Kaplan-Meier Estimate Immunity, Humoral Recombinant Proteins Cytokines Amino Acid Sequence Leucovorin Adjuvants, Anesthesia Triazoles Lymphocyte Activation Dose-Response Relationship, Immunologic Vaccines, Inactivated Receptor, erbB-2 Cisplatin Disease Models, Animal Prospective Studies Anthracyclines Hemocyanin Influenza Vaccines Immunotherapy Antibodies, Bacterial Injections, Subcutaneous Antimetabolites, Antineoplastic Antibodies, Viral Antibodies, Monoclonal Immunohistochemistry Tumor Markers, Biological Administration, Oral

No FAQ available that match "conjunction adjuvants immunologic"